Anti-SARS-CoV-2 IgG Antibody Titers in Cotemporary lots of Intravenous Immune Globulin and Fresh Frozen Plasma Compared to COVID Convalescent Plasma.

IF 8.2 1区医学 Q1 IMMUNOLOGY

Clinical Infectious Diseases Pub Date : 2025-02-03 DOI:10.1093/cid/ciaf045

Ethan A Smith, Ginny M Javier, Ashrit Multani, Omer Eugene Beaird, Pryce Gaynor, Lauren Yanagimoto-Ogawa, Joanna Schaenman, Paul Allyn, George Alfarhat, Tara Vijayan, Alyssa Ziman, Omai Garner

引用次数: 0

Abstract

Given declining COVID convalescent plasma (CCP) collection and increasing scarcity, we compared anti-SARS-CoV-2 IgG antibody titers between CCP, intravenous immunoglobulin (IVIG) and fresh frozen plasma (FFP). Herein, we report comparative anti-SARS-CoV-2 IgG antibody titers between five lots of each blood product, using the DiaSorin Liaison® SARS-CoV-2 TrimericS IgG assay.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Infectious Diseases 医学-传染病学

CiteScore

25.00

自引率

2.50%

发文量

900

审稿时长

3 months

期刊介绍： Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.